Literature DB >> 28083691

Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium.

Orazio Schillaci1,2, Nicoletta Urbano3.   

Abstract

Mesh：

Year:  2017        PMID： 28083691     DOI： 10.1007/s00259-017-3616-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  25 in total

1.  Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer.

Authors:  Kenji Kawada; Yuji Nakamoto; Mayumi Kawada; Koya Hida; Takuya Matsumoto; Teppei Murakami; Suguru Hasegawa; Kaori Togashi; Yoshiharu Sakai
Journal:  Clin Cancer Res       Date:  2012-01-26       Impact factor: 12.531

2.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

3.  18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.

Authors:  Joseph R Osborne; Elisa Port; Mithat Gonen; Ashley Doane; Henry Yeung; William Gerald; Josh B Cook; Steven Larson
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

4.  Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.

Authors:  Viswam S Nair; Olivier Gevaert; Guido Davidzon; Sandy Napel; Edward E Graves; Chuong D Hoang; Joseph B Shrager; Andrew Quon; Daniel L Rubin; Sylvia K Plevritis
Journal:  Cancer Res       Date:  2012-06-18       Impact factor: 12.701

5.  K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Authors:  Christos S Karapetis; Shirin Khambata-Ford; Derek J Jonker; Chris J O'Callaghan; Dongsheng Tu; Niall C Tebbutt; R John Simes; Haji Chalchal; Jeremy D Shapiro; Sonia Robitaille; Timothy J Price; Lois Shepherd; Heather-Jane Au; Christiane Langer; Malcolm J Moore; John R Zalcberg
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

6.  Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.

Authors:  Eung-Sirk Lee; Dae-Soon Son; Sung-Hyun Kim; Jinseon Lee; Jisuk Jo; Joungho Han; Heesue Kim; Hyun Joo Lee; Hye Young Choi; Youngja Jung; Miyeon Park; Yu Sung Lim; Kwhanmien Kim; YoungMog Shim; Byung Chul Kim; Kyusang Lee; Nam Huh; Christopher Ko; Kyunghee Park; Jae Won Lee; Yong Soo Choi; Jhingook Kim
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

7.  Correlation of dynamic PET and gene array data in patients with gastrointestinal stromal tumors.

Authors:  Ludwig G Strauss; Antonia Dimitrakopoulou-Strauss; Dirk Koczan; Leyun Pan; Peter Hohenberger
Journal:  ScientificWorldJournal       Date:  2012-06-04

8.  ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor.

Authors:  Lori Rink; Michael F Ochs; Yan Zhou; Margaret von Mehren; Andrew K Godwin
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

9.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

10.  Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.

Authors:  Jae-Hoon Lee; Jeonghyun Kang; Seung Hyuk Baik; Kang Young Lee; Beom Jin Lim; Tae Joo Jeon; Young Hoon Ryu; Seung-Kook Sohn
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
View more
  6 in total

1.  Digital PET/CT: a new intriguing chance for clinical nuclear medicine and personalized molecular imaging.

Authors:  Orazio Schillaci; Nicoletta Urbano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-11       Impact factor: 9.236

Review 2.  Radiogenomics Based on PET Imaging.

Authors:  Yong-Jin Park; Mu Heon Shin; Seung Hwan Moon
Journal:  Nucl Med Mol Imaging       Date:  2020-05-09

3.  An Ad Hoc Random Initialization Deep Neural Network Architecture for Discriminating Malignant Breast Cancer Lesions in Mammographic Images.

Authors:  Andrea Duggento; Marco Aiello; Carlo Cavaliere; Giuseppe L Cascella; Davide Cascella; Giovanni Conte; Maria Guerrisi; Nicola Toschi
Journal:  Contrast Media Mol Imaging       Date:  2019-05-22       Impact factor: 3.161

Review 4.  Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.

Authors:  Orazio Schillaci; Manuel Scimeca; Nicola Toschi; Rita Bonfiglio; Nicoletta Urbano; Elena Bonanno
Journal:  Contrast Media Mol Imaging       Date:  2019-07-01       Impact factor: 3.161

5.  Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with 99mTc and 177Lu as Potential Receptor Radiopharmaceuticals.

Authors:  Agnieszka Majkowska-Pilip; Przemysław Koźmiński; Anna Wawrzynowska; Tadeusz Budlewski; Bogusław Kostkiewicz; Ewa Gniazdowska
Journal:  Molecules       Date:  2018-10-05       Impact factor: 4.411

6.  Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations.

Authors:  Gahyun Kim; Jinho Kim; Se-Hoon Lee; Seung Hwan Moon; Hongui Cha; Woong-Yang Park; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Yong-Jin Park; Joon Young Choi; Kyung-Han Lee
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.